Back to Atlas
CTransientStandard research/education caution
CMP-0335
Experimental
Frag 176-191 / AOD derivative
Thermogenic
Fat-loss positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide
- Primary mechanism
- GH-fragment lipolytic signaling proposed
- Primary market use
- Weight management
Pharmacology
- Molecular weight (Da)
- ~1815
- Oral bioavailability
- N/A
- Half-life
- ~30 min; not established
- Route tags
- Route-dependent / verify
- Evidence level
- Human/research
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
SQ: • 500 mcg first thing every morning, then wait an hour before food (World of Peptides)
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Requires ongoing dosing